Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
FDA establishment 3000279201, Burnaby, Canada. Part of Creation Technologies's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations.
Inspections: 2
Official action indicated: 1
Warning letters: 1
Import refusals since 2014: 3
Inspections by fiscal year
FY2018 to FY2027 to date; 1 classified OAI
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
21 CFR 820.90(a). Nonconforming product, Lack of or inadequate procedures Procedures have not been adequately established to control product that does not conform to specified requirements.
21 CFR 820.198(a). Lack of or inadequate complaint procedures Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established.
21 CFR 820.50. Purchasing controls, Lack of or inadequate procedures Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements have not been adequately established.
21 CFR 820.100(a). Lack of or inadequate procedures Procedures for corrective and preventive action have not been adequately established.
21 CFR 820.100(a). Lack of or inadequate procedures The procedures for implementing corrective and preventive actions were not complete and implemented.
21 CFR 820.120. Lack of or inadequate procedures for labeling Labeling procedures were not defined, documented, and implemented.
21 CFR 820.75(a). Documentation Process validation activities and results have not been fully documented.
21 CFR 820.40(a). Document review, approval documentation The documentation of approval of documents does not include the signature of the approving official. Electronic signatures based on identification codes/passwords are used, but they do not meet the uniqueness, individual identity verification, electronic signature certification, non-biometric component, non-biometric component use control, non-biometric genuine owner use, non-biometric administration and execution design, biometric use design, and id/password device/token testing requirements of 21 CFR Part 11.
21 CFR 820.22. Quality audits - Lack of or inadequate procedures Procedures for conducting quality audits were not complete.
21 CFR 820.120(b). DHR documentation of label release {see also 820.184} The DHR does not include records of approval and release of device labeling, including date and signature of the examiner.
21 CFR 820.80(a). Lack of or inadequate procedures - Acceptance activities Procedures for acceptance activities were not complete and implemented.
Voluntary Action Indicated (VAI)
Warning letters
Letters naming this establishment; each opens the letter
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections.FDA Data Dashboard, warning letters and enforcement reports